Skip to main content
. 2012 Dec 11;15(2):316–323. doi: 10.1208/s12248-012-9439-1

Fig. 1.

Fig. 1

Study design. Superscript a Oral medication not allowed within 3 h of the start of infusion on the pharmacokinetic assessment day. Superscript b If oral medication was needed, final pharmacokinetic sample was taken prior to oral treatment. ECG electrocardiogram, LC levodopa/carbidopa, PK pharmacokinetic assessment, VS vital sign assessment